CoChat
Sign Up
Cited by 127Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia

Open access
Landqvist Waldö, Maria, Frizell Santillo, Alexander, Passant, Ulla, Zetterberg, Henrik, Rosengren, Lars, Nilsson, Christer, Englund, Elisabet·2013·BMC Neurology
DOI 10.1186/1471-2377-13-54PMC PMC3671150
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Frontotemporal dementia (FTD) is recognised as a clinically and morphologically heterogeneous group of interrelated neurodegenerative conditions. One of the subtypes within this disease spectrum is the behavioural variant FTD (bvFTD). This is known to be a varied disorder with a mixture of tau-positive and tau-negative underlying pathologies. The other subtypes include semantic dementia (SD), which generally exhibits tau-negative pathology, and progressive non-fluent aphasia (PNFA), which is usually tau-positive. As the clinical presentation of these subtypes may overlap, a specific diagnosis can be difficult to attain and today no specific biomarker can predict the underlying pathology. Neurofilament light chain protein (NFL), a cytoskeletal constituent of intermediate filaments, is thought to reflect neuronal and axonal death when appearing in the cerebrospinal fluid (CSF). NFL has been shown to be elevated in CSF in patients with FTD compared with AD and controls. Our hypothesis was that the levels of NFL also differ between the subtypes of FTD and may indicate the underlying pathological subtype. METHODS: We retrospectively analysed data from previous CSF analyses in 34 FTD cases (23 bvFTD, seven SD, four PNFA), 20 AD cases, and 26 healthy controls. A separate group of 10 neuropathologically verified and subtyped FTD cases (seven tau-negative, three tau-positive) were also analysed. RESULT: NFL levels were significantly higher in FTD compared with both AD (p<0.001) and controls (p<0.001). The NFL levels of SD and bvFTD were significantly higher (p<0.001) compared with AD. The biomarker profiles of PNFA and AD were similar. In the neuropathologically verified FTD cases, NFL was higher in the tau-negative than in the tau-positive cases (exact p=0.017). CONCLUSIONS: The marked NFL elevation in some but not all FTD cases is likely to reflect the different underlying pathologies. The highest NFL values found in the SD group as well as in the neuropathologically verified tau-negative cases may be of subtype diagnostic value, if corroborated in larger patient cohorts. In bvFTD, a mixture of tau-positive and tau-negative underlying pathologies could possibly explain the intermediate NFL values.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2377-13-54

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Boxplot with individual values of NFL in each clinical subtype. The number of subjects in each subtype: bvFTD n=23, SD n=7, PNFA n=4, AD n=20, healthy controls n=26. The detection limit of NFL was 250 ng/l.
Figure 1 Boxplot with individual values of NFL in each clinical subtype. The number of subjects in each subtype: bvFTD n=23, SD n=7, PNFA n=4, AD n=20, healthy controls n=26. The detection limit of NFL was 250 ng/l.CC BY · PubMed Central
Figure 2 Scatter of NFL values in each neuropathological subtype. The number of subjects in each subtype: tau-positive n=3, tau-negative n=7. The detection limit of NFL was 250 ng/l.
Figure 2 Scatter of NFL values in each neuropathological subtype. The number of subjects in each subtype: tau-positive n=3, tau-negative n=7. The detection limit of NFL was 250 ng/l.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 127

Related

See all

Metadata

Authors
Landqvist Waldö, M., Frizell Santillo, A., Passant, U., Zetterberg, H., Rosengren, L., Nilsson, C., & Englund, E.
Affiliations
  • Skåne University Hospital (SE)
  • National Hospital for Neurology and Neurosurgery (GB)
  • University of Gothenburg (SE)
  • Lund University (SE)
ORCID
Venue
BMC Neurology
Publisher
Springer Science and Business Media LLC
Published
2013-05-29
Volume
13
Issue
1
Pages
54-54
ISSN
1471-2377 (ISSN-L)
DOI
10.1186/1471-2377-13-54
PMC
PMC3671150
OpenAlex
W2141909536
Cited by
127
References
35
Citations by year
2025: 8 · 2024: 1 · 2023: 3 · 2022: 10 · 2021: 7 · 2020: 9 · 2019: 13 · 2018: 22 · 2017: 18 · 2016: 10 · 2015: 12 · 2014: 10 · 2013: 3
FWCI
7.14
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Gothenburg University Publications Electronic Archive (Gothenburg University) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion, other-oa)
Funders
Region Skåne
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
frontotemporal dementia, neurofilament light chain, cerebrospinal fluid biomarkers, behavioral variant frontotemporal dementia, semantic dementia, progressive nonfluent aphasia, tau pathology, Alzheimer's disease, neuronal cell death
MeSH terms
Adult, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Female, Humans, Male, Middle Aged, Neurologic Examination, Peptide Fragments, Retrospective Studies, Spinal Puncture, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Statistics, Nonparametric, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review